Evidence map›Paper›PMID 39487123›Full record

ArticleNature communications2024

Optogenetic patterning generates multi-strain biofilms with spatially distributed antibiotic resistance.

Xiaofan Jin, Ingmar H Riedel-Kruse

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Microbial medicines: Unlocking the therapeutic potential of the microbiome in cancer treatment.Journal of controlled release : official journal of the Controlled Release Society · 2026
    Review
  4. Article
  5. Review
  6. Article
  7. Dissecting the physics of bacterial biofilms with agent-based simulations.Current opinion in solid state & materials science · 2025
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Xiaofan JinGladstone Institutes, San Francisco, CA, USA. xiaofan.jin@ucalgary.ca.ORCID 0000-0002-0802-7692
Ingmar H Riedel-KruseDepartment of Molecular and Cellular Biology (and by courtesy) Applied Mathematics, Biomedical Engineering, and Physics, University of Arizona, Tucson, AZ, USA. ingmar@arizona.edu.ORCID 0000-0002-6068-5561

Funding

From synthetic bacterial adhesions to synthetic bacterial materialsR01GM145893 · NIGMS · UNIVERSITY OF ARIZONA · PI RIEDEL-KRUSE, HANS INGMAR · 2022 to 2025
$1.2M
Biofilm Lithography: A newparadigm to optically control and study biofilm growth dynamicsR21AI139941 · NIAID · UNIVERSITY OF ARIZONA · PI RIEDEL-KRUSE, HANS INGMAR, SPORMANN, ALFRED M · 2018 to 2019
$432k
NIAID NIH HHS R21 AI139941NIGMS NIH HHS R01 GM145893
6 · The paper itself

Abstract

Spatial organization of microbes in biofilms enables crucial community function such as division of labor. However, quantitative understanding of such emergent community properties remains limited due to a scarcity of tools for patterning heterogeneous biofilms. Here we develop a synthetic optogenetic toolkit 'Multipattern Biofilm Lithography' for rational engineering and orthogonal patterning of multi-strain biofilms, inspired by successive adhesion and phenotypic differentiation in natural biofilms. We apply this toolkit to profile the growth dynamics of heterogeneous biofilm communities, and observe the emergence of spatially modulated commensal relationships due to shared antibiotic protection against the beta-lactam ampicillin. Supported by biophysical modeling, these results yield in-vivo measurements of key parameters, e.g., molecular beta-lactamase production per cell and length scale of antibiotic zone of protection. Our toolbox and associated findings provide quantitative insights into the spatial organization and distributed antibiotic protection within biofilms, with direct implications for future biofilm research and engineering.

Indexed as

AmpicillinAnti-Bacterial AgentsBiofilmsOptogeneticsbeta-LactamasesDrug Resistance, MicrobialAmpicillinAnti-Bacterial Agentsbeta-Lactamases

Identifiers

PMID39487123
PMCPMC11530673

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.